NM_001330260.2:c.4748T>C

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 3P and 10B. PM1PP2BP4BP6BS1BS2

The NM_001330260.2(SCN8A):​c.4748T>C​(p.Ile1583Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000467 in 1,613,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I1583V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00049 ( 0 hom. )

Consequence

SCN8A
NM_001330260.2 missense

Scores

3
8
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8O:1

Conservation

PhyloP100: 5.09

Publications

10 publications found
Variant links:
Genes affected
SCN8A (HGNC:10596): (sodium voltage-gated channel alpha subunit 8) This gene encodes a member of the sodium channel alpha subunit gene family. The encoded protein forms the ion pore region of the voltage-gated sodium channel. This protein is essential for the rapid membrane depolarization that occurs during the formation of the action potential in excitable neurons. Mutations in this gene are associated with cognitive disability, pancerebellar atrophy and ataxia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
SCN8A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 13
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • cognitive impairment with or without cerebellar ataxia
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • seizures, benign familial infantile, 5
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • benign familial infantile epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile convulsions and choreoathetosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myoclonus, familial, 2
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

PM1
In a repeat IV (size 297) in uniprot entity SCN8A_HUMAN there are 71 pathogenic changes around while only 13 benign (85%) in NM_001330260.2
PP2
Missense variant in the SCN8A gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 213 curated pathogenic missense variants (we use a threshold of 10). The gene has 45 curated benign missense variants. Gene score misZ: 0.78755 (below the threshold of 3.09). Trascript score misZ: 10.436 (above the threshold of 3.09). GenCC associations: The gene is linked to myoclonus, familial, 2, developmental and epileptic encephalopathy, 13, undetermined early-onset epileptic encephalopathy, benign familial infantile epilepsy, complex neurodevelopmental disorder, seizures, benign familial infantile, 5, cognitive impairment with or without cerebellar ataxia, infantile convulsions and choreoathetosis.
BP4
Computational evidence support a benign effect (MetaRNN=0.41254112).
BP6
Variant 12-51794594-T-C is Benign according to our data. Variant chr12-51794594-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 130248. Variant chr12-51794594-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 130248. Variant chr12-51794594-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 130248. Variant chr12-51794594-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 130248. Variant chr12-51794594-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 130248. Variant chr12-51794594-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 130248. Variant chr12-51794594-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 130248. Variant chr12-51794594-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 130248. Variant chr12-51794594-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 130248. Variant chr12-51794594-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 130248. Variant chr12-51794594-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 130248.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000256 (39/152196) while in subpopulation NFE AF = 0.000485 (33/68026). AF 95% confidence interval is 0.000355. There are 0 homozygotes in GnomAd4. There are 15 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 39 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN8ANM_001330260.2 linkc.4748T>C p.Ile1583Thr missense_variant Exon 26 of 27 ENST00000627620.5 NP_001317189.1 Q9UQD0-2Q6B4S4
SCN8ANM_014191.4 linkc.4748T>C p.Ile1583Thr missense_variant Exon 26 of 27 ENST00000354534.11 NP_055006.1 Q9UQD0-1
SCN8ANM_001177984.3 linkc.4625T>C p.Ile1542Thr missense_variant Exon 25 of 26 NP_001171455.1 Q9UQD0-5
SCN8ANM_001369788.1 linkc.4625T>C p.Ile1542Thr missense_variant Exon 25 of 26 NP_001356717.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN8AENST00000354534.11 linkc.4748T>C p.Ile1583Thr missense_variant Exon 26 of 27 1 NM_014191.4 ENSP00000346534.4 Q9UQD0-1
SCN8AENST00000627620.5 linkc.4748T>C p.Ile1583Thr missense_variant Exon 26 of 27 5 NM_001330260.2 ENSP00000487583.2 Q9UQD0-2
SCN8AENST00000599343.5 linkc.4781T>C p.Ile1594Thr missense_variant Exon 25 of 26 5 ENSP00000476447.3 Q9UQD0-3
SCN8AENST00000355133.7 linkc.4625T>C p.Ile1542Thr missense_variant Exon 24 of 25 1 ENSP00000347255.4 Q9UQD0-5

Frequencies

GnomAD3 genomes
AF:
0.000256
AC:
39
AN:
152196
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000485
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000205
AC:
51
AN:
249166
AF XY:
0.000185
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.000398
Gnomad OTH exome
AF:
0.000331
GnomAD4 exome
AF:
0.000488
AC:
714
AN:
1461704
Hom.:
0
Cov.:
32
AF XY:
0.000470
AC XY:
342
AN XY:
727132
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.000150
AC:
8
AN:
53402
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000617
AC:
686
AN:
1111864
Other (OTH)
AF:
0.000315
AC:
19
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
34
69
103
138
172
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000256
AC:
39
AN:
152196
Hom.:
0
Cov.:
32
AF XY:
0.000202
AC XY:
15
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41446
American (AMR)
AF:
0.0000654
AC:
1
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000485
AC:
33
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000424
Hom.:
0
Bravo
AF:
0.000268
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000241
AC:
1
ESP6500EA
AF:
0.000118
AC:
1
ExAC
AF:
0.000198
AC:
24
EpiCase
AF:
0.000436
EpiControl
AF:
0.000830

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:5
Mar 19, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The majority of missense variants in this gene are considered pathogenic (Stenson et al., 2014); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 32090326, 26220391, 33083721) -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SCN8A: PP2, BS2 -

Jan 02, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
Mar 24, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: SCN8A c.4748T>C (p.Ile1583Thr) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0002 in 249166 control chromosomes, predominantly at a frequency of 0.0004 within the Non-Finnish European subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in SCN8A causing Early Infantile Epileptic Encephalopathy 13, allowing no conclusion about variant significance. c.4748T>C has been reported in the literature in two individuals affected with epilepsy (Brunklaus_2020, Dong_2020), without strong evidence for causality . These report(s) do not provide unequivocal conclusions about association of the variant with Early Infantile Epileptic Encephalopathy 13. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. ClinVar contains an entry for this variant (Variation ID: 130248). Based on the evidence outlined above, the variant was classified as likely benign. -

Inborn genetic diseases Benign:1
Feb 09, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Developmental and epileptic encephalopathy Benign:1
Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 13 Other:1
-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
0.0060
T
BayesDel_noAF
Uncertain
0.090
CADD
Uncertain
24
DANN
Benign
0.34
DEOGEN2
Uncertain
0.79
D;.;.;.;.
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.78
T;T;.;T;T
M_CAP
Pathogenic
0.34
D
MetaRNN
Benign
0.41
T;T;T;T;T
MetaSVM
Pathogenic
0.97
D
MutationAssessor
Benign
1.9
L;.;.;.;L
PhyloP100
5.1
PrimateAI
Uncertain
0.76
T
PROVEAN
Uncertain
-3.0
D;D;D;.;.
REVEL
Pathogenic
0.71
Sift
Uncertain
0.0040
D;D;D;.;.
Sift4G
Benign
0.66
T;T;T;T;T
Polyphen
0.90
P;.;.;.;.
Vest4
0.54
MVP
0.80
MPC
1.8
ClinPred
0.19
T
GERP RS
4.9
Varity_R
0.48
gMVP
0.84
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201458257; hg19: chr12-52188378; API